Traveling abroad for business can be tricky
Familiarity with a foreign culture and its traditions can mean the difference between success and failure, or at least avoiding embarrassment.
Familiarity with a foreign culture and its traditions can mean the difference between success and failure, or at least avoiding embarrassment.
When it comes to health care reform, Eli Lilly and Co. has its derriere exposed more than its drugmaker peers.
Indiana exports eked out a gain in 2008 despite the imploding world economy-rising 2 percent to $26.5 billion, according to preliminary data from the U.S. Department of Commerce. All things considered, “exports held up pretty well last year. The last 60 days of the year is really the first time we saw deterioration on the […]
When it comes to health care reform, Eli Lilly and Co. has its derriere exposed more than its drugmaker peers. That’s according to a recent report by Jason Napodano, a senior pharmaceutical analyst at Zack’s Equity Research. In an April 9 report, he examined potential negatives in President Barack Obama’s health care reform outline. While […]
Indiana is becoming not only a hotbed of “pharmacogenomics” research, but also a trailblazer in finding practical ways to
use it on the practitioner level.
Prescribe the wrong dose and some drugs won’t work. Or the patient is as good as dead. Consider the rat-poison-turned-blood-thinner warfarin, also known as Coumadin. Too much and a patient can bleed to death, too little and he can throw a clot and have a stroke. Given the considerable consequences of improper dosing for patients-and […]
Eli Lilly and Co. has sold the rights to sell the diabetes drug Actos in seven countries to Takeda Pharmaceutical Co., Asia’s biggest drugmaker, Bloomberg News reported this morning. Takeda will sell Actos in Canada, Belgium, Denmark, Norway, Sweden and Turkey, a company spokesman told Bloomberg yesterday. Terms of the deal were not disclosed. Takeda […]
Eli Lilly and Co. has launched its new blood thinner prasugrel in its first market, the United Kingdom, Reuters reported today. The drug, sold under the brand name Efient, is priced 31-percent higher than its rival Plavix, the world’s leading blood thinner. Plavix, sold by New York-based Bristol-Myers Squibb Co. and French company Sanofi Aventis […]
Eli Lilly and Co. has launched its new blood thinner prasugrel in its first market, the United Kingdom, Reuters reported today. The drug, sold under the brand name Efient, is priced 31-percent higher than its rival Plavix, the world’s leading blood thinner. Plavix, sold by New York-based Bristol-Myers Squibb Co. and French company Sanofi Aventis […]
Modern-day bounty hunters are preparing to fan out across Indiana as the U.S. Department of Health and Human Services expands a program to ferret out fraud and overpayment in the health care system.
Eli Lilly and Co. and two drug-development partners said a once-weekly version of the diabetes medicine Byetta proved better at lowering patients’ blood sugar than two competing drugs. Lilly is working with California-based Amylin Pharmaceuticals Inc. and Massachusetts-based Alkermes Inc. to bring once-weekly Byetta, also called exanatide, to market by 2010. The drug is currently […]
CEO John Lechleiter is ruling out Eli Lilly and Co.’s participation in the drug industry’s recent round of mega-mergers, the Financial Times reported today. At the same time, the Indianapolis-based company isn’t stepping back from collaborations. It announced its most recent today: a heart-drug development deal with Mumbai, India-based Cadila Healthcare Ltd. Lechleiter specifically ruled […]
CEO John Lechleiter is ruling out Eli Lilly and Co.’s participation in the drug industry’s recent round of mega-mergers, the Financial Times reported today. At the same time, the Indianapolis-based company isn’t stepping back from collaborations. It announced its most recent today: a heart-drug development deal with Mumbai, India-based Cadila Healthcare Ltd. Lechleiter specifically ruled […]
My wife, Becky, is alive today because of Lilly and its trial drug Enzastaurin, a great surgeon, and a terrific team of local doctors.
Despite the bad economy, the Indianapolis Indians’ franchise could make a record amount of money in 2009.
The hiring of minority- and women-owned
businesses to work on the $275 million Indiana Convention Center expansion is far ahead of state requirements and has surpassed
rates that were registered for the $715 million Lucas Oil Stadium project.
Indianapolis-based Eli Lilly and Co.’s experimental drug for schizophrenia did not prove in its latest test that it works better than existing medication, the company announced today. The drug showed promise in an early study two years ago, but Lilly said the drug performed inconclusively in a Phase II clinical trial. The drug maker said […]
The hiring of minority- and women-owned businesses to work on the $275 million Indiana Convention Center expansion is far ahead of state requirements and has surpassed rates that were registered for the $715 million Lucas Oil Stadium project. More than 28 percent of the $215 million in bids awarded so far has gone to minority- […]
At a time when many professional sports teams are seeing their revenue drop in the wake of a rocky economy, the Indianapolis Indians are driving in runs. The AAA minor-league baseball team’s sponsorship revenue this year has already nearly matched what the franchise brought in all of last year, and could be on its way […]
A new group funded by pharmaceutical and medical products companies – and co-chaired by former Indianapolis Mayor Bart Peterson and Indiana Pacers President Jim Morris – will publicly launch itself today with a press event at the Indiana Statehouse. Hoosiers Work for Health is a not-for-profit that wants to hold educational forums about health care […]